Alcohol 70% Versus Chlorhexidine 0.5% in the Spinal Anesthesia Skin Antissepsis
1 other identifier
interventional
70
1 country
1
Brief Summary
Context: The neuraxial blocks, spinal anesthesia and epidural anesthesia are among the most frequently performed procedures worldwide, and despite the advancements of medical equipment, remain dependent on experience and practice of the anesthesiologists. Although antisepsis takes part of the daily routine, there are still no solid scientific evidence of the most appropriate antiseptic for these procedures. Objective: To compare the 70% alcohol and 0.5% chlorhexidine alcohol solution in skin antisepsis for the neuraxial blocks. Methods: This is a clinical trial, a prospective, randomized study. There will be selected, consecutively, 70 patients candidates for neuraxial blocks. Patients will be randomly assigned to group A (n = 35), in which the antisepsis will be performed with alcohol 70%, and to group B (n = 35), in which the antiseptic will be performed with the 0.5% chlorhexidine in alcoholic solution. Samples will be collected with swabs in an area of 25 cm² for bacterial cultures three times: in pre-antisepsis moments, in the second minute after antisepsis, and immediately after the puncture. The number of colonies forming units per square centimeter (CFU / cm²) will be counted. The data will be analyzed statistically.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 30, 2016
CompletedFirst Submitted
Initial submission to the registry
July 5, 2016
CompletedFirst Posted
Study publicly available on registry
July 14, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 6, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2017
CompletedDecember 13, 2017
July 1, 2016
7 months
July 5, 2016
December 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Skin colonization before and after antisepsis, Will be counted number of colonies forming units per square centimeter (CFU/cm²)
The material will be collected in a pre determined field of 25 cm², with a swab, and the maximum seeding in 8 hours, 48 hours after will be counted the number of colonies forming units per square centimeter (CFU/cm²)
Before antisepsis
Skin colonization before and after antisepsis, Will be counted number of colonies forming units per square centimeter (CFU/cm²)
The material will be collected in a pre determined field of 25 cm², with a swab, and the maximum seeding in 8 hours, 48 hours after will be counted the number of colonies forming units per square centimeter (CFU/cm²)
2 minutes after antisepsis
Skin colonization before and after antisepsis, Will be counted number of colonies forming units per square centimeter (CFU/cm²)
The material will be collected in a pre determined field of 25 cm², with a swab, and the maximum seeding in 8 hours, 48 hours after will be counted the number of colonies forming units per square centimeter (CFU/cm²)
After the Puncture and at most 40 minutes
Study Arms (2)
Alcohol group
EXPERIMENTALPatients allocated to this group will receive skin antisepsis with alcohol 70% prior spinal anesthesia
Chlorhexidine group
EXPERIMENTALPatients allocated to this group will receive skin antisepsis with alcoholic solution of chlorhexidine 0.5% prior spinal anesthesia
Interventions
Eligibility Criteria
You may qualify if:
- Patients between 18 and 65 years of age , without restriction as to sex, ethnicity, education or social class;
- Patients who are undergoing neuraxial blockade by indicating the anesthesiologist responsible for the procedure
You may not qualify if:
- comorbidities or conditions which constitute a contraindication for the neuroaxial block ;
- Body mass index (BMI ) greater than 30 kg / m2;
- Ongoing infection;
- Use of antibiotics in the last seven days;
- Skin lesions at the puncture site ;
- Refusal to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital e Maternidade Santa Paula
Pouso Alegre, Minas Gerais, 37550-000, Brazil
Related Publications (1)
Tostes LCS, Loyola ABAT, Fraga AO, Gazzi LA, Paiva LF, Juliano Y, Veiga DF. Alcohol (70%) versus alcoholic chlorhexidine solution (0.5%) in skin antisepsis for neuraxial blocks: a randomized clinical trial. Rev Col Bras Cir. 2021 Jan 13;48:e20202633. doi: 10.1590/0100-6991e-20202633. eCollection 2021.
PMID: 33470369DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Daniela F Veiga, MD, PhD
Universidade do Vale do Sapucai
- STUDY DIRECTOR
Ana Beatriz A Loyola, PhD
Universidade do Vale do Sapucai
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
July 5, 2016
First Posted
July 14, 2016
Study Start
May 30, 2016
Primary Completion
January 6, 2017
Study Completion
January 30, 2017
Last Updated
December 13, 2017
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will not share